Newsroom-Katalog
Zeit | benfovir AG: Meldungen vom 12.10.2022 |
---|---|
11:10 | benfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT) |
Zeit | benfovir AG: Meldungen vom 12.10.2022 |
---|---|
11:10 | benfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT) |